Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MIRCEA PETRINA

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1861624009
CMS profile
356892
Location
THORNTON, CO

General Payments · PY2018–2024

$9,015.04

  • Reported across 196 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$635.67

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $792.84 33
PY2019 $4,936.58 63
PY2020 $64.33 3
PY2021 $304.52 16
PY2022 $1,092.82 35
PY2023 $1,188.28 31
PY2024 $635.67 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $23.68 04/25/2024 Food and Beverage Undisputed 01/23/2026 1125309440 CMS
ABIOMED $31.73 03/06/2024 Food and Beverage Undisputed 01/23/2026 1142221198 CMS
AstraZeneca Pharmaceuticals LP $117.15 06/19/2024 Food and Beverage Undisputed 01/23/2026 1105353303 CMS
AstraZeneca Pharmaceuticals LP $18.19 09/25/2024 Food and Beverage Undisputed 01/23/2026 1104296802 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.18 01/25/2024 Food and Beverage Undisputed 01/23/2026 1118195486 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $120.89 04/18/2024 Food and Beverage Undisputed 01/23/2026 1118195491 CMS
E.R. Squibb & Sons, L.L.C. $25.15 05/22/2024 Food and Beverage Undisputed 01/23/2026 1101851812 CMS
HEARTFLOW, INC. $20.75 01/11/2024 Food and Beverage Undisputed 01/23/2026 1154167474 CMS
Janssen Pharmaceuticals, Inc $16.45 03/14/2024 Food and Beverage Undisputed 01/23/2026 1077948160 CMS
Lexicon Pharmaceuticals, Inc. $18.82 05/08/2024 Food and Beverage Undisputed 01/23/2026 1081734427 CMS
Medicure Pharma Inc. $13.34 02/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1089506620 CMS
Novo Nordisk Inc $16.36 02/28/2024 Food and Beverage Undisputed 01/23/2026 1097795797 CMS
Philips North America LLC $22.39 05/16/2024 Food and Beverage Undisputed 01/23/2026 1146877879 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $125.00 03/11/2024 Food and Beverage Undisputed 01/23/2026 1080666187 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $36.59 10/23/2024 Food and Beverage Undisputed 01/23/2026 1080666201 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.